|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
46.35 Million
|
|
Market
Size (2030)
|
USD
70.94 Million
|
|
CAGR
(2025-2030)
|
7.35%
|
|
Fastest
Growing Segment
|
Urine
Test
|
|
Largest
Market
|
East
India
|
Market Overview
India
Kidney Function Test Market was valued at USD 46.35 million in 2024 and is
expected to reach USD 70.94 million by 2030 with a CAGR of 7.35% during the
forecast period. This can be ascribed to the increased awareness about kidney
diseases, that how it is important to detect kidney diseases early and to raise
awareness among the people regarding kidney diseases in India. There has been a
significant increase in the prevalence of kidney diseases in India over the
last few decades. This increase is mainly attributed to changes in lifestyle,
including unhealthy diets, lack of physical activity, and an increase in the
prevalence of diabetes and hypertension. Patients are more informed about the
benefits of early detection of kidney diseases, as a result, there is a growing
need for early detection and management of kidney disease, which has led to an
increase in demand for kidney function tests. These advancements have improved
the accuracy and reliability of the tests, leading to greater acceptance of the
tests by patients and healthcare professionals. Indian government has taken so
many initiatives to improve healthcare in the country, including measures to
increase access to kidney function tests.
For
instance, the National Health Mission in India provides free diagnostic tests,
including kidney function tests, to eligible individuals, which has helped to
increase access to these tests. As the growing Indian economy has led to
greater investments in healthcare infrastructure, including diagnostic labs and
testing facilities, it has helped to fuel the growth of the India kidney
function test market.
Key Market Drivers
Increasing
Prevalence of Chronic Kidney Disease
Chronic
kidney disease (CKD) is a major public health concern in India, and the
prevalence of the disease has been increasing in recent years. Around 10% of
the Indian population suffers from chronic kidney disease, and every year over
1 lakh cases of renal failure. There are several factors that have
contributed to the rising incidence of CKD in India, including Diabetes which
is one of the leading causes of chronic kidney disease in India.
According
to the International Diabetes Federation, India has the second-largest
population of people with diabetes in the world, with an estimated 77 million
people affected.
Hypertension or high blood pressure is another major contributor to the
development of chronic kidney disease in India. Hypertension is common in
India, with an estimated 25-30% of the adult population affected. Unhealthy
lifestyle choices, such as a diet high in salt and fat, lack of physical
activity, and tobacco use, are also contributing to the increasing prevalence
of chronic kidney disease in India. India has a high proportion of aged
population, and older adults are more likely to develop chronic kidney disease
than younger individuals. Environmental factors such as exposure to
environmental toxins and pollution can also contribute to the development of
chronic kidney disease. The increasing prevalence of chronic kidney disease in
India has significant implications for public health, as the disease can lead
to serious complications such as kidney failure, cardiovascular disease, and
premature death. Early detection and management of this disease are critical in
reducing the burden of the disease in India, and kidney function tests play an
important role in achieving this goal. These factors are anticipated to grow
the India kidney function test market.
Growing
Awareness regarding Kidney Diseases
There
has been a growing awareness about kidney disease in India in recent years.
Several factors have contributed to this awareness, including Increasing
prevalence of kidney disease in India has led to increased attention and
awareness about the disease among the public. The Indian government has
launched several initiatives aimed at raising awareness about kidney disease,
such as the National Program for Prevention and the National Health Mission.
The Indian media has played a significant role in raising awareness about
kidney disease through articles, television shows, and other forms of media.
Patient advocacy groups, several patient advocacy groups in India are working
to raise awareness about kidney disease and the importance of early detection
and management. Healthcare professionals, including doctors and nurses, are
also playing a critical role in raising awareness about kidney disease and
encouraging patients to undergo kidney function tests for early detection of
kidney disease.
The
growing awareness about kidney disease in India is helping to improve early
detection and management of the disease. This is important in reducing the
burden of kidney disease in India, which has significant implications for
public health and the economy. These factors are anticipated to grow the India
kidney function test market.
Download Free Sample Report
Key Market Challenges
Limited Access to Healthcare
in Rural Areas
One
of the primary challenges in the India kidney function test market is the
limited access to healthcare, especially in rural and remote areas. Many
regions in India lack adequate healthcare infrastructure, making it difficult
for individuals to undergo routine kidney function tests like serum creatinine,
blood urea nitrogen (BUN), and glomerular filtration rate (GFR). In rural
areas, there is often a shortage of diagnostic centers equipped with advanced
testing equipment and skilled healthcare personnel. This limits early detection
and monitoring of kidney diseases, which are prevalent in India due to factors
such as diabetes, hypertension, and high rates of chronic kidney disease (CKD).
Overcoming this challenge requires significant investments in infrastructure,
awareness campaigns, and mobile diagnostic solutions to ensure better access to
kidney function tests for underserved populations.
High Cost of Advanced
Diagnostic Technologies
The
high cost of advanced kidney function testing technologies is another major
challenge in the market. Tests like GFR and molecular-based diagnostics can be
expensive, particularly in the private healthcare sector, which limits
accessibility for lower-income populations. Additionally, the need for
specialized equipment and skilled technicians further increases the cost of
these tests. This financial barrier often prevents timely detection and
effective management of kidney diseases. While basic tests such as serum
creatinine and BUN are more affordable, they may not provide a comprehensive
understanding of kidney health. Making advanced kidney function tests more
affordable and accessible is crucial to improving the overall management of
kidney diseases in India.
Key Market Trends
Increasing Adoption of
Point-of-Care (POC) Testing
A
growing trend in India’s kidney function test market is the increasing adoption
of Point-of-Care (POC) testing. POC testing allows for quick and accurate
results at the patient's location, eliminating the need for laboratory visits.
This is especially beneficial in rural and remote areas, where access to
diagnostic centers is limited. Devices like portable creatinine analyzers and
handheld diagnostic kits are gaining popularity, enabling healthcare
professionals to monitor kidney function in real-time. These tests provide
immediate results, making them invaluable for managing chronic kidney disease
(CKD) and acute kidney injury (AKI). The ease of use and affordability of POC
tests are driving their uptake in both primary healthcare settings and mobile
health units, ensuring that kidney function testing becomes more accessible to
a broader segment of the population. As healthcare providers continue to invest
in these technologies, the adoption of POC testing is expected to grow,
particularly for high-risk individuals in rural regions.
Shift Toward Integrated and
Comprehensive Kidney Health Monitoring Solutions
Another
emerging trend is the shift toward integrated and comprehensive kidney health
monitoring solutions. Traditional kidney function tests, such as serum
creatinine and BUN, are increasingly being complemented by more advanced
diagnostic tools, including urine albumin-to-creatinine ratio (ACR) tests and
genetic screening. Integrated platforms that combine various diagnostic tests,
patient data, and real-time monitoring are gaining traction, offering a more
holistic approach to kidney health management. The integration of technologies
like artificial intelligence (AI) and machine learning into kidney function
testing is also on the rise. These innovations can help healthcare providers
identify early-stage kidney damage, predict disease progression, and personalize
treatment plans for patients. With CKD becoming a significant public health
concern in India, the demand for comprehensive and integrated solutions for
monitoring kidney health is expected to grow, driving market development and
improving outcomes for patients.
Segmental Insights
Component Insights
Based
on component, the dipsticks category is currently dominating the India Kidney
Function Test market due to their affordability, ease of use, and efficiency in
providing rapid results. Dipsticks, also known as urine test strips, are widely
used for initial screening and monitoring of kidney function. They are designed
to detect a range of parameters such as protein, glucose, pH, specific gravity,
and the presence of other substances like blood or ketones in urine, which are
indicative of kidney health.
One
of the key factors driving the dominance of dipsticks in the market is their
low cost, making them accessible for widespread use, especially in
resource-constrained settings and rural areas. These test strips provide quick
results, making them ideal for point-of-care (POC) testing, where immediate
feedback is needed for timely diagnosis and treatment. Dipsticks are commonly
used in outpatient clinics, diagnostic centers, and even at home for routine
monitoring of kidney function, particularly in individuals with risk factors
such as diabetes, hypertension, or a family history of kidney disease.
Moreover,
the simplicity of using dipsticks, requiring minimal training for healthcare
providers and patients, contributes to their popularity. This ease of use is
vital in improving early detection and continuous monitoring of kidney
conditions, helping reduce the burden of chronic kidney disease (CKD) and acute
kidney injury (AKI) in India. As healthcare accessibility improves and
awareness about kidney health grows, the dipstick category is expected to
maintain its dominance in the kidney function test market, especially for
routine and preliminary screening purposes.
Download Free Sample Report
Regional Insights
Based
on the region, East India was dominating in India Kidney Function Test Market in
2024, driven by the increasing prevalence of kidney diseases, particularly
chronic kidney disease (CKD), and the growing demand for diagnostic services.
States like West Bengal, Odisha, Bihar, Jharkhand, and Assam have seen rising
rates of conditions such as diabetes and hypertension, which are major risk
factors for kidney disease. The high incidence of these diseases in the region
has significantly contributed to the demand for kidney function tests like
serum creatinine, blood urea nitrogen (BUN), and urine tests.
The
region's dominance can also be attributed to several healthcare developments.
East India is witnessing improvements in healthcare infrastructure, with
diagnostic centers, hospitals, and clinics expanding to meet the growing need
for kidney function testing. The adoption of cost-effective and accessible
diagnostic tools, such as dipsticks for initial screening and point-of-care
(POC) devices, is further driving the growth in the region. Additionally,
mobile health units and government-led initiatives aimed at improving
healthcare access are ensuring that even underserved areas can benefit from
these diagnostic services.
Key Market Players
- Abbott India Ltd
- Roche Diagnostics India Pvt. Ltd
- Siemens Healthineers India
- Bio-Rad Laboratories (India) Pvt. Ltd
- Inbios India
- Swemed Bio Medicals Private Limited
- Merck KGaA
- Danaher Corporation
|
By Test Type
|
By Component
|
By End User
|
By Region
|
- Urine
Test
- Urine
Protein Tests
- Creatinine
Clearance Tests
- Microalbumin
Tests
- Blood
Test
- Serum
Creatinine Tests
- Glomerular
Filtration Rate Tests
- Blood
Urea Nitrogen Tests
|
- Dipsticks
- Reagents
- Kits
& Essays
|
- Hospitals
and Clinics
- Diagnostics
Laboratories
- Academic
and Research Institute
|
- North
India
- South
India
- East
India
- West
India
|
Report Scope:
In this report, the India Kidney Function Test Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- India Kidney Function Test Market, By Test Type:
o Urine Test
o Urine Protein Tests
o Creatinine Clearance Tests
o Microalbumin Tests
o Blood Test
o Serum Creatinine Tests
o Glomerular Filtration Rate Tests
o Blood Urea Nitrogen Tests
- India Kidney Function Test Market, By Component:
o Dipsticks
o Reagents
o Kits & Essays
- India Kidney Function Test Market, By End User:
o Hospitals and Clinics
o Diagnostics Laboratories
o Academic and Research Institute
- India Kidney Function Test Market, By Region:
o North India
o South India
o East India
o West India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the India Kidney
Function Test Market.
Available Customizations:
India Kidney Function Test Market report
with the given market data, TechSci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India Kidney Function Test Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at sales@techsciresearch.com